<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_FQgxfNm">Integrated Text Messaging (ITM) for people attending cardiac and pulmonary rehabilitation: A multicentre randomised controlled trial</title>
				<funder>
					<orgName type="full">National Heart Foundation of Australia</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001030</idno>
				</funder>
				<funder ref="#_wBPcWrq #_4qgH6vP #_n3sjZej">
					<orgName type="full">NHMRC</orgName>
				</funder>
				<funder ref="#_JkyKVHA">
					<orgName type="full">University of Sydney</orgName>
					<orgName type="abbreviated">USYD</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001774</idno>
				</funder>
				<funder ref="#_GTck5KM">
					<orgName type="full">National Heart Foundation 2015</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Julie</forename><surname>Redfern</surname></persName>
							<email>julie.redfern@sydney.edu.au</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Charles Perkins Centre , University of Sydney ; The George Institute for Global Health , University of New South Wales , NSW , Australia</note>
								<orgName type="department" key="dep1">Charles Perkins Centre</orgName>
								<orgName type="department" key="dep2">The George Institute for Global Health</orgName>
								<orgName type="institution" key="instit1">University of Sydney</orgName>
								<orgName type="institution" key="instit2">University of New South Wales</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><forename type="middle">C</forename><surname>Singleton</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rebecca</forename><surname>Raeside</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> MPH , Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="laboratory">MPH</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karla</forename><surname>Santo</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>d</label> Hospital Israelita Albert Einstein , Academic Research Organization , São Paulo , Brazil</note>
								<orgName type="department" key="dep1">Hospital Israelita Albert Einstein</orgName>
								<orgName type="department" key="dep2">Academic Research Organization</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> The George Institute for Global Health , University of New South Wales , NSW , Australia</note>
								<orgName type="department">The George Institute for Global Health</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nashid</forename><surname>Hafiz</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> MIPH , Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="laboratory">MIPH</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lissa</forename><surname>Spencer</surname></persName>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>g</label> PhD, Department of Physiotherapy , Royal Prince Alfred Hospital , Sydney Local Health District , NSW , Australia</note>
								<orgName type="department">Department of Physiotherapy</orgName>
								<orgName type="institution" key="instit1">Royal Prince Alfred Hospital</orgName>
								<orgName type="institution" key="instit2">Sydney Local Health District</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Leung</surname></persName>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>h</label> PhD, Department of Thoracic Medicine , Concord Repatriation General Hospital , Sydney Local Health District , NSW , Australia</note>
								<orgName type="department">Department of Thoracic Medicine</orgName>
								<orgName type="institution" key="instit1">Concord Repatriation General Hospital</orgName>
								<orgName type="institution" key="instit2">Sydney Local Health District</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><surname>Roberts</surname></persName>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>i</label> MPal Care , Department of Respiratory and Sleep Medicine , Westmead Hospital , Western Sydney Local Health District , NSW , Australia</note>
								<orgName type="department" key="dep1">MPal Care</orgName>
								<orgName type="department" key="dep2">Department of Respiratory and Sleep Medicine</orgName>
								<orgName type="institution" key="instit1">Westmead Hospital</orgName>
								<orgName type="institution" key="instit2">Western Sydney Local Health District</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>j</label> Faculty of Medicine and Health , The University of Sydney at Westmead Hospital , NSW , Australia</note>
								<orgName type="department">Faculty of Medicine and Health</orgName>
								<orgName type="institution">The University of Sydney at Westmead Hospital</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Meredith</forename><surname>King</surname></persName>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>k</label> B Physiotherapy , Chronic Disease Community Rehabilitation Service , Northern Sydney Local Health District , NSW , Australia</note>
								<orgName type="department" key="dep1">B Physiotherapy</orgName>
								<orgName type="department" key="dep2">Chronic Disease Community Rehabilitation Service</orgName>
								<orgName type="institution">Northern Sydney Local Health District</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jin-Gun</forename><surname>Cho</surname></persName>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>l</label> PhD, Department of Respiratory and Sleep Medicine , Westmead Hospital , NSW , Australia</note>
								<orgName type="department">Department of Respiratory and Sleep Medicine</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<note type="raw_affiliation"><label>m</label> Faculty of Medicine and Health , University of Sydney at Westmead Hospital , Australia</note>
								<orgName type="department">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney at Westmead Hospital</orgName>
								<address>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bridie</forename><surname>Carr</surname></persName>
							<affiliation key="aff13">
								<note type="raw_affiliation"><label>n</label> BA Comms , NSW Agency for Clinical Innovation , NSW , Australia</note>
								<orgName type="department">BA Comms</orgName>
								<orgName type="institution">NSW Agency for Clinical Innovation</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Jenkins</surname></persName>
							<affiliation key="aff14">
								<note type="raw_affiliation"><label>o</label> PhD, The George Institute for Global Health , Sydney and UNSW Faculty of Medicine and Health , NSW , Australia</note>
								<orgName type="department">UNSW Faculty of Medicine and Health</orgName>
								<orgName type="institution">The George Institute for Global Health</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><forename type="middle">R</forename><surname>Partridge</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<note type="raw_affiliation"><label>p</label> Charles Perkins Centre , University of Sydney , Australia</note>
								<orgName type="department">Charles Perkins Centre</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alison</forename><surname>Hayes</surname></persName>
							<affiliation key="aff16">
								<note type="raw_affiliation"><label>q</label> PhD, School of Public Health , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">School of Public Health</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clara</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
							<affiliation key="aff17">
								<note type="raw_affiliation"><label>r</label> PhD, Westmead Applied Research Centre , Faculty of Medicine and Health , University of Sydney ; Western Sydney Local Health District ; The George Institute for Global Health , University of New South Wales , NSW , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep3">Health District</orgName>
								<orgName type="department" key="dep4">The George Institute for Global Health</orgName>
								<orgName type="institution" key="instit1">University of Sydney</orgName>
								<orgName type="institution" key="instit2">Western Sydney Local</orgName>
								<orgName type="institution" key="instit3">University of New South Wales</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karice</forename><surname>Hyun</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Engagement and Co-design Research Hub , School of Health Sciences , Faculty of Medicine and Health , University of Sydney , NSW , Australia</note>
								<orgName type="department" key="dep1">Engagement and Co-design Research Hub</orgName>
								<orgName type="department" key="dep2">School of Health Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine and Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<note type="raw_affiliation"><label>s</label> Department of Cardiology , Concord Repatriation General Hospital , Sydney Local Health District , NSW , Australia</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Concord Repatriation General Hospital</orgName>
								<orgName type="institution" key="instit2">Sydney Local Health District</orgName>
								<address>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<note type="raw_affiliation">University of Sydney at Westmead Hospital , Block K , Westmead Hospital , Hawkesbury Road , Westmead , NSW , Australia.</note>
								<orgName type="institution">University of Sydney at Westmead Hospital</orgName>
								<address>
									<addrLine>Block K Westmead Hospital Hawkesbury Road</addrLine>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_KMpgFvz">Integrated Text Messaging (ITM) for people attending cardiac and pulmonary rehabilitation: A multicentre randomised controlled trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">1834EB1B9D5D1E8B54CF9EB8FF0E098D</idno>
					<idno type="DOI">10.1016/j.rehab.2023.101800</idno>
					<note type="submission">Received 28 February 2023 Accepted 17 October 2023</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:02+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_XJyjDMt">Cardiac rehabilitation Pulmonary rehabilitation Heart disease Chronic obstructive pulmonary disease Digital health 6MWD, 6-minute walk distance</term>
					<term xml:id="_nwG9m92">ANCOVA, analysis of covariance</term>
					<term xml:id="_95JtNZQ">BMI, body mass index</term>
					<term xml:id="_wvtnqC8">CAT, COPD Assessment Test</term>
					<term xml:id="_PhF2FBN">CHD, coronary heart disease</term>
					<term xml:id="_9VCNQJK">CI, confidence interval</term>
					<term xml:id="_rKAYCUD">COPD, chronic obstructive pulmonary disease</term>
					<term xml:id="_xkUZcSa">CVD, cardiovascular disease</term>
					<term xml:id="_Tjuydu7">HREC, Human Research Ethics Committee</term>
					<term xml:id="_femqnrR">ITM, Integrated text messaging</term>
					<term xml:id="_CvJD2YC">METS, metabolic equivalent</term>
					<term xml:id="_jRy6JZj">MRC, Medical Research Council</term>
					<term xml:id="_ZRexsfT">PREMs, patient-reported experience measures</term>
					<term xml:id="_Q23RuyE">PROMs, patient-reported outcome measures</term>
					<term xml:id="_pm83JqK">QOL, quality of life</term>
					<term xml:id="_ZJYqrM3">RCT, randomised controlled trial</term>
					<term xml:id="_QZUG6ph">SD, standard deviation</term>
					<term xml:id="_B3uPWxU">SIM, Subscriber Identity Module</term>
					<term xml:id="_f9guX6s">TEXTME, Tobacco, Exercise and Diet Messages trial</term>
					<term xml:id="_XSTbhuM">WHO, World Health Organisation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_XVpA4b8"><p xml:id="_58vVT3R"><s xml:id="_DYUzn5S">Background: People living with cardiac and respiratory disease require improved post-hospital support that is readily available and efficient.</s><s xml:id="_cfmFsP7">Objectives: To 1) test the effectiveness of an automated, semi-personalised text message support program on clinical and lifestyle outcomes amongst people attending cardiac and pulmonary rehabilitation.</s><s xml:id="_XUDgetx">Also, 2) to evaluate the program's acceptability and utility using patient-reported outcome and experience measures.</s><s xml:id="_k2DEEru">Methods: Multicentre randomised controlled trial (3:1, intervention:control) amongst cardiac and pulmonary rehabilitation attendees.</s><s xml:id="_2Dydy5W">Control received usual care (no message program).</s><s xml:id="_HVEQMkd">Intervention also received a 6month text message lifestyle and support program.</s><s xml:id="_ZdwZw4v">Primary outcome was 6-minute walk distance (6MWD).</s><s xml:id="_DCFMPur">Secondary outcomes included clinical measures, lifestyle, patient-reported outcome and experience measures, medication adherence and rehabilitation attendance.</s><s xml:id="_bC5H6xM">Results: A total of 316 participants were recruited.</s><s xml:id="_ceGzcpF">They had a mean age of 66.7 (SD 10.1) years.</s><s xml:id="_VN8Msgp">Sixty percent were male (190/316) and 156 were cardiac rehabilitation participants.</s><s xml:id="_8gkPG84">The cohort's mean baseline 6MWD was higher in the intervention than the control group.</s><s xml:id="_CG9dWBq">At 6 months, 6MWD improved in both groups; it was significantly greater amongst intervention than control participants (unadjusted mean difference of 43.4 m, 95 % CI 4.3 to 82.4; P = 0.0296).</s><s xml:id="_WDkYRDc">After adjustment for baseline values, there was no significant difference between intervention and control groups for 6MWD (adjusted mean difference 2.2 m, -21.2 to 25.6; P = 0¢ 85), medication adherence, or cardiovascular risk factors.</s><s xml:id="_FuVN4D3">At 6-month follow-up, intervention participants</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vmNcpcR">Introduction</head><p xml:id="_yesUGqF"><s xml:id="_duXTevn">According to the World Health Organisation (WHO), the top 10 causes of death accounted for 55 % of the 55. <ref type="bibr" target="#b3">4</ref> million deaths worldwide in 2019 <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_bh8NJpP">Ischaemic heart disease, stroke and chronic obstructive pulmonary disease (COPD) were the top 3 causes of death globally in 2019 and were responsible for 16 %, 11 % and 6 % of deaths respectively <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_MwjprJw">Despite the COVID-19 global pandemic, heart disease remained the top cause of death in the USA in 2020 <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_geNjXGq">Heart disease and chronic respiratory disease are also 2 of the chronic diseases responsible for high rates of avoidable hospital admissions <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_PgpmK2P">Around half of all people admitted to hospital with coronary heart disease (CHD) have experienced a previous acute coronary syndrome <ref type="bibr" target="#b3">[4]</ref> and only 1/4 are discharged with the appropriate combination of evidence-based medicines, lifestyle advice (eg, smoking cessation, physical activity, or diet) and referral to rehabilitation <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_KZG4XWY">Moreover, the majority do not adhere to lifestyle modification advice or evidenced-based pharmacotherapy <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_E5DtdpT">Similarly for COPD, exacerbations result in 700,000 hospitalisations annually in the United States and an estimated 20 % of these are followed by a further readmission within 1 month <ref type="bibr" target="#b6">[7]</ref>, creating a cost burden of over $US15 billion each year <ref type="bibr" target="#b7">[8]</ref>.</s></p><p xml:id="_FeZxMnF"><s xml:id="_jH99d5J">Cardiac and pulmonary rehabilitation programs are widely available as a strategy to support ongoing management, lifestyle changes and risk factor management for people with heart and lung disease <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s xml:id="_NT485RB">These programs are commonly delivered by multidisciplinary teams as in-person and group-based programs via local hospitals and community centres <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s xml:id="_nzV3QAT">The programs usually run over 2-3 months and are based around supervised exercise sessions and education about risk factors.</s><s xml:id="_CQcdpTJ">The focus is on quality of life, behaviour change, goal-setting and self-management of the condition/s <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s xml:id="_vWNryj5">Both cardiac and pulmonary rehabilitation programs have been shown to be effective in reducing hospital readmissions; improving clinical outcomes, medication adherence and health-related quality of life <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s xml:id="_udceDQV">However, research has consistently reported that enrolment and completion rates are commonly below 30 % for those who have been recommended to attend based on guidelines <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_9hgBA9K">This attrition was exacerbated by the COVID-19 global pandemic, resulting in closure of many in-person and group-based services along with increased challenges for face-to-face attendance <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s xml:id="_unaT2hg">Therefore, effective and efficient approaches are needed to improve outcomes for people with cardiac and pulmonary disease, along with an increased efficiency of services.</s><s xml:id="_edbN4yE">Given that both programs follow a similar structure, and have similar goals, it was determined that a similar support program for both forms of rehabilitation could be evaluated in a single study.</s></p><p xml:id="_WYNWzvd"><s xml:id="_XFy8UMM">The increasing availability and ownership of mobile devices provides an opportunity to provide support to people offered cardiac and pulmonary rehabilitation to improve their self-management and increase participation.</s><s xml:id="_EU7B5wj">Previous clinical trials have reported on the effectiveness of text messaging in improving smoking cessation, <ref type="bibr" target="#b14">[15]</ref> and increasing weight loss <ref type="bibr" target="#b15">[16]</ref> and physical activity <ref type="bibr" target="#b16">[17]</ref>.</s><s xml:id="_hKxGDcm">One example is the Tobacco, Exercise and Diet Messages (TEXTME) trial which found that people with heart disease who received a 6-month semi-personalised program of text messages achieved significant improvements to their cardiovascular risk factors compared to those who did not <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_gNwz3J8">The intervention was also reported to be engaging, useful and helpful <ref type="bibr" target="#b18">[19]</ref> as well as being cost effective <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_P2xE6kx">A similar program has not yet been used for people with COPD.</s><s xml:id="_JJwjUHE">Therefore, the primary aim of this study was to report on the implementation of an integrated text message (ITM) support program for people with chronic cardiovascular disease (CVD) and/or chronic respiratory disease who were attending cardiac and pulmonary rehabilitation programs following their discharge from hospital <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_PUDAZrp">Secondary aims were to determine which factors enhanced their participation, and to explore the acceptability and usability of a text message based self-management and support program in parallel with traditional cardiac and pulmonary rehabilitation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pqUG5Cx">MATERIALS and METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kwHATQy">Study design</head><p xml:id="_YJah8Yy"><s xml:id="_mCHQ9Ur">This was a multicentre, single-blind randomised controlled trial (RCT) with clinical and patient-reported outcomes at 6 months postrandomisation <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_MEUvNny">The protocol is published elsewhere and was implemented without deviation <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_spbWmQk">Briefly, participants were recruited from hospital sites in Sydney, Australia, and randomised at a ratio of 3:1 into either receiving a 6-month text message support program plus usual care (intervention) or usual care alone (control).</s><s xml:id="_ndpsQVY">Participants were stratified according to whether they were participating in cardiac or pulmonary rehabilitation <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_8wNBYbD">Clinical, behavioural, and quality of life (QOL) data were recorded during face-to-face assessments at baseline and 6 months.</s><s xml:id="_68jaRmA">Written and informed consent was obtained from all participants and the study followed the CON-SORT guidelines <ref type="bibr" target="#b21">[22]</ref>.</s><s xml:id="_E4sZZfY">Ethical approval was received from the Sydney Local Health District Hospital Human Research Ethics Committee (HREC/16/RPAH/362) and associated Governance committees at each site.</s><s xml:id="_RY4bDNU">The study was sponsored by the University of Sydney.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9Qwphdg">Participants</head><p xml:id="_NZnkTMe"><s xml:id="_GVNDkEu">Inclusion criteria were: i) adults (≥18 years of age); ii) own a mobile phone with an active Subscriber Identity Module (SIM) card; iii) presented to either a cardiac or pulmonary rehabilitation service with a history of either CVD or chronic respiratory disease at a participating hospital.</s><s xml:id="_skDgbnk">CVD conditions included CHD, cardiomyopathy, peripheral arterial disease, stroke, arrhythmias and aneurysms.</s><s xml:id="_2wRajqZ">Chronic respiratory diseases included chronic bronchitis, bronchiectasis, emphysema, and chronic asthma.</s><s xml:id="_vhA5UvW">Exclusion criteria were i) unwilling to comply with the trial for 6 months or (ii) insufficient understanding of English, the language used in the text messages.</s><s xml:id="_GGhamZN">Potential participants were consecutively identified by cardiac and pulmonary rehabilitation clinical staff or the research team, then screened for eligibility and invited to participate by the research assistants.</s><s xml:id="_nQEeUvQ">Eligible and interested participants were contacted by a study research assistant to obtain written informed consent prior to randomisation and collection of data.</s><s xml:id="_seTJkJY">All participants were able to continue with standard cardiac or pulmonary rehabilitation as clinically indicated and attendance was logged in rehabilitation program records.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Y49Kfw6">Randomisation and concealment</head><p xml:id="_mrDuJFC"><s xml:id="_N5qWRye">Participants were randomised to either usual, usual care (control) or usual and text messaging program (intervention) by computerised randomisation.</s><s xml:id="_KkXQdEx">Randomisation was independent and stratified according to pulmonary or cardiac rehabilitation.</s><s xml:id="_VQDgvrN">Because the study was a pragmatic implementation trial, participants were individually randomised at a ratio of 3:1 (intervention:control).</s><s xml:id="_tP5a6CZ">This enabled more participants to receive the text message program.</s><s xml:id="_h9AsgbS">All study personnel, including the study statistician and those recording follow-up measures, were blinded to group allocation.</s><s xml:id="_NT2XdPP">Participants were asked to not discuss if they were receiving the text messages during their follow-up visit.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hCgNz2w">Study procedures</head><p xml:id="_YuT5rU3"><s xml:id="_4SzfgFT">Once recruited, participants' baseline data were collected, and they were allocated to either the control or intervention group.</s><s xml:id="_3rrbwhH">Participants allocated to the control group received a single introductory text message stating they would be contacted for follow-up at 6 months.</s><s xml:id="_ZwKHd2H">Participants allocated to control were offered the messaging program at no cost after their 6-month follow-up.</s></p><p xml:id="_XsyY9jE"><s xml:id="_a8NDW2Y">Participants allocated to the intervention group were digitally registered for the 6-month automated text message program (example messages are provided in Supplemental Material, Table <ref type="table" target="#tab_0">S1</ref>).</s><s xml:id="_QpwGMKG">Messages were evidence-based, founded on behavioural psychology, and delivered according to our previously published model <ref type="bibr" target="#b22">[23]</ref>.</s><s xml:id="_P82Wdwf">Messages were unidirectional, semi-personalised (preferred name, cardiac/pulmonary, vegetarian, smoker/not) and sent from a purposebuilt web-based platform.</s><s xml:id="_EJSBSQk">Participants in the intervention group received 5 messages per week for 26 weeks at random times on random days, to minimise habituation.</s><s xml:id="_5TA47Sb">This approach was chosen in accordance with our previous quantitative and qualitative research <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25]</ref>.</s><s xml:id="_xU8PMhf">Although participants were encouraged not to respond to messages, all replies were monitored for safety via a centrally located research assistant with a clinical background.</s></p><p xml:id="_5h3SCxb"><s xml:id="_3wBKkD4">Messages provided supportive content for 6 months about selfmanagement relating to medication adherence, attendance at rehabilitation, and lifestyle change.</s><s xml:id="_hPpanUN">Following our previously published process, message content development involved literature reviews, surveys, and information taken from the focus group feedback of people with cardiac and pulmonary diseases who had been recruited from chronic disease programs.</s><s xml:id="_vF3jqJk">For cardiac rehabilitation messages, the primary content concerned general CVD health, smoking cessation, physical activity, and nutrition (Table <ref type="table" target="#tab_0">S1</ref>).</s><s xml:id="_tQECAwJ">For the pulmonary rehabilitation messages, content was primarily about general respiratory health, physical activity, smoking cessation, symptom management and symptom monitoring (Table <ref type="table" target="#tab_0">S1</ref>).</s><s xml:id="_5A7FDdT">Both the cardiac and pulmonary programs included content supporting medication adherence and participation in rehabilitation.</s><s xml:id="_JxuHnnE">Each week, messages were selected by the software system from the message bank based on prespecified algorithms that varied content about the major areas for each condition.</s><s xml:id="_4hu5bTK">No message was repeated during the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NAac3vE">Outcomes</head><p xml:id="_kgvSzMY"><s xml:id="_znwb9EB">Data were collected at baseline and 6 months.</s><s xml:id="_YSKcsWA">At baseline, demographic information, medical history, and clinical measures were collected.</s><s xml:id="_vtYZtQa">After 6 months, outcomes were collected by a research assistant blinded to group allocation.</s><s xml:id="_ZmfkR5M">The primary outcome was the 6-minute walk distance (6MWD), a clinically-validated assessment of exercise capacity <ref type="bibr" target="#b25">[26]</ref> demonstrated to be reliable for populations with cardiac or respiratory diseases.</s><s xml:id="_Y4B5CRj">The 6MWD test followed a standardised study protocol using the same instructions and equipment between sites <ref type="bibr" target="#b26">[27]</ref>.</s><s xml:id="_8R3SXAj">Secondary outcomes (Supplemental Material, Table <ref type="table" target="#tab_1">S2</ref>) included clinical and lifestyle measures such as body mass index (BMI) <ref type="bibr" target="#b27">[28]</ref>, smoking status <ref type="bibr" target="#b28">[29]</ref>, physical activity <ref type="bibr" target="#b29">[30]</ref>, and diet <ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_79rFx7n">Other measures recorded included patient-reported outcome measures (PROMs), such as quality of life <ref type="bibr" target="#b31">[32]</ref>, anxiety and depression scores <ref type="bibr" target="#b32">[33]</ref>, and the impact of COPD on wellbeing <ref type="bibr" target="#b33">[34]</ref>, patient-reported experience measures (PREMs), such as user satisfaction, and process measures, like software analytical data (for a full list, see Table <ref type="table" target="#tab_1">S2</ref>).</s></p><p xml:id="_gEXERw4"><s xml:id="_un3YnDm">Participants attending pulmonary rehabilitation were also asked about their perceived breathlessness and this was classified using the Medical Research Council (MRC) dyspnoea scale <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_9M8CRDy">On this scale, a grade of 3, 4, or 5 corresponds to moderate-to-severely disabling COPD; a higher grade represents more severe breathlessness <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_tnkWjXc">The COPD Assessment Test (CAT) was also completed for participants with COPD <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_cx9qqWV">The CAT score is an externally-validated questionnaire that contains 8 questions covering domains relating to the impact of COPD symptoms <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_WT38xse">CAT scores range from 0 to 40; higher scores denote a more severe impact of COPD on the person's life <ref type="bibr" target="#b33">[34]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nFWfj6B">Statistical analysis</head><p xml:id="_4mvvxTd"><s xml:id="_PFgEVQ4">As per the study protocol, we estimated a sample size of 310 (150 cardiac, 160 respiratory) people would provide 90 % power and enable observation of a clinically meaningful difference in 6MWD scores in the intervention group compared to controls, for both cardiac (23.3 m) <ref type="bibr" target="#b35">[36]</ref> and pulmonary (30.0 m) <ref type="bibr" target="#b36">[37]</ref> rehabilitation participants.</s><s xml:id="_pt9FEz5">Calculations allowed for a 20 % drop-out rate.</s><s xml:id="_TedcWFw">The significance level of the test was 0.05.</s></p><p xml:id="_EB5RWtz"><s xml:id="_us9NWue">Analyses were specified and performed according to the intention-to-treat principle by a statistician blinded to group allocation; full details have previously been published <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_A4ZXZ3q">Baseline data are presented as proportions for categorical data, or as means and standard deviations (SD) for continuous data.</s><s xml:id="_U93MM6P">Primary and secondary outcomes were summarised as means and corresponding 95 % confidence intervals (CI) for normally distributed continuous outcomes, and as median and interquartile intervals for skewed outcomes.</s><s xml:id="_Kfsv8NF">Categorical outcomes were reported as frequencies and percentages.</s><s xml:id="_VQVex69">Outcomes were compared using all available data with intervention and control groups compared at 6 months.</s><s xml:id="_8rsSbNR">Normally distributed continuous outcomes were analysed using the analysis of covariance (ANCOVA).</s><s xml:id="_3m39f57">The skewed continuous outcome of metabolic equivalents (METS) was categorised into quartiles (&lt;600 min/week, 600-1449 min/week, 1450-2649 min/week, ≥2650 min/week) and analysed using an adjusted ordinal regression.</s><s xml:id="_h9ar675">Dichotomous outcomes were analysed using adjusted log-binomial regression.</s><s xml:id="_Ayhvfk3">Adjusted analyses were performed when those participating in cardiac and pulmonary rehabilitation were analysed separately, and the baseline value of the outcome variable was included in the models as an independent variable.</s><s xml:id="_55ct6eK">When analysing the cardiac and pulmonary groups together, an additional independent variable of whether the participants attended cardiac or pulmonary rehabilitation was included.</s></p><p xml:id="_gmFeS9a"><s xml:id="_zSr8SyJ">Pre-specified subgroup analyses of the primary outcome were conducted according to the following baseline data: rehabilitation (cardiac vs pulmonary); sex (male vs female); age (≤65 years vs &gt;65 years); physical activity at baseline (METS&lt;600 min/week vs ≥600 min/week); and participation in rehabilitation (attended &lt;50% vs ≥50 % sessions).</s><s xml:id="_SGRfjJv">Analysis for each subgroup was performed by adding the subgroup variable as well as its interaction with the intervention as fixed effects to the log-binomial regression model used for the primary analysis.</s></p><p xml:id="_a9QQZfU"><s xml:id="_MyJ75Vf">After discounting the estimated 20 % dropout, primary outcome data were missing in 6 % of the total cohort (0.5 % in cardiac and 11 % in pulmonary).</s><s xml:id="_YvNfXT7">As there were missing primary outcome measurements at follow-up and data were likely to be missing at random, sensitivity analysis was performed using multiple imputation of 20 iterations.</s><s xml:id="_6BtChTd">The auxiliary variables to estimate missing data were 6MWD at follow-up, and age, sex, education, employment, CVD, COPD, sleep apnoea, Type 2 diabetes, hypertension, high cholesterol, depression, BMI and 6MWD at baseline.</s><s xml:id="_93CSDXR">A P-value &lt;0.05 was considered statistically significant.</s><s xml:id="_dcTYzRe">Analysis was performed using SAS software (version 9.4, SAS Institute Inc., Cary, NC, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jYJCgZV">RESULTS</head><p xml:id="_6sArmFe"><s xml:id="_ahPsVdx">The first participant was recruited to the study in May 2017 and the final follow-up was completed in June 2019.</s><s xml:id="_PkBG9Qj">In total, 581 potential participants were screened and, of these, 265 were not eligible for inclusion or declined participation, and 316 were enroled (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_ZGEbuBn">Recruitment closed when the sample size target was reached.</s><s xml:id="_uBjzSUn">At the end of the study, 19 participants had withdrawn, 26 were unable to be contacted and 4 (1 cardiac and 3 pulmonary) had died (Fig. <ref type="figure" target="#fig_0">1</ref>).</s></p><p xml:id="_pR4GFCU"><s xml:id="_zmvu52G">Demographic characteristics of the participants along with clinical and lifestyle measures are summarised in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_b9z3R7D">At baseline, the mean age of the cohort was 66.7 years (63 years for those receiving cardiac rehabilitation, and 69 years for those in the pulmonary group), 60 % were men, 49 % (156) participated in cardiac rehabilitation and 51 % (160) in pulmonary rehabilitation, 35 % had experienced a prior myocardial infarction, 18 % were diagnosed with type 2 diabetes, and 14 % were current smokers.</s><s xml:id="_AeUyGsW">Of the 125 who provided ethnicity data, 98 (78 %) were Caucasian, 13 (10 %) were Asian.</s><s xml:id="_EAU7KDm">In addition, 58 % (111/191) were either married or living with a partner, 25 % (72/285) were working and 41 % (117/285) were retired.</s><s xml:id="_mqXC8A5">Anxiety and depression scores were comparable between the control and the intervention groups at baseline: mean anxiety scores were 6.3 (SD 3.8) vs 5.7 (SD 4.2) and mean depression scores were 5.6 (SD 3.9) vs 5.1 (SD 3.3).</s><s xml:id="_aU9BEvD">Similarly, mean CAT scores were similar between the 2 groups at 21.1 (SD 7.8) vs 21.2 (SD 7.3).</s></p><p xml:id="_AXph8dS"><s xml:id="_TdpDV2k">Of those attending cardiac rehabilitation, more participants in the intervention group 42 % (52/123) had previously had a myocardial infarction compared to 29 % (9/31) of the control group, although a similar proportion had received diagnoses of either cardiomyopathy (9/123, 7% vs 4/31, 13 %), peripheral vascular disease (3/124, 2% vs 1/ 30, 3 %) although slightly fewer in the intervention group had a prior transient ischaemic attack or stroke (4/122, 3% vs 2/31, 6 %).</s><s xml:id="_PgZ2Nub">Of those attending pulmonary rehabilitation, a similar proportion in the intervention and control groups required oxygen (8/107, 7% vs 3/49, 6 %) or had a chest condition in the past 12 months that required antibiotics or steroids (37/46, 80% vs 76/102, 74 %).</s><s xml:id="_bKsrMBk">For participants attending pulmonary rehabilitation, the mean MRC dyspnoea scale scores indicated that breathlessness was similar for the intervention (3.0, SD  1.1) and control groups (2.7, SD 1.0).</s><s xml:id="_6uTwJY9">For the total cohort, mean oxygen saturation was also similar for the intervention and control groups before (96.5, SD 2.4 vs 95.9, SD 2.3) and after (93.3, SD 8.5 vs 92.1, SD 5.9) the 6MWD test was completed.</s><s xml:id="_huRMnBE">Similarly, Borg scale results immediately after the 6MWD were similar for the intervention (2.4,</s><s xml:id="_SbNE9RK">SD 1.6) and control (2.8, SD 1.8) groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9pZaac9">Primary and secondary outcomes</head><p xml:id="_5vqcqVj"><s xml:id="_Sq7zyUY">The mean 6MWD increased from baseline to 6-month follow-up in both the intervention (from 427.8 m, 95 % CI 412.6 to 442.9 at baseline to 477.9 m, 95 % CI 458.5 to 497.4 at 6 months) and control groups (from 383.5 m, 95 % CI 357.3 to 409.6 at baseline to 434.5 m, 95 % CI 400.7 to 468.4 at 6 months).</s><s xml:id="_D8UCzUX">At 6 months, 6MWD was significantly greater in intervention than control participants (unadjusted mean difference 43.4 m, 95 % CI 4.3 to 82.4; P = 0.0296).</s><s xml:id="_GkqFqdH">However, this difference did not remain; adjusted analyses revealed no significant differences between the intervention and control groups in the primary outcome of 6MWD at 6 months (adjusted mean difference 2.2 m, 95 % CI À21.2 to 25.6).</s><s xml:id="_XGPxDEc">Similarly, sensitivity analysis using multiple imputation showed no difference in 6MWD between the 2 groups (5.2 m, 95 % CI À19.1 to 29.6).</s></p><p xml:id="_M6ETShD"><s xml:id="_sAFfkk2">There were also no statistically significant differences at 6 months between the intervention and control groups for secondary outcomes of mean blood pressure, BMI, waist circumference, proportion of current smokers, physical activity, or nutrition (Table <ref type="table" target="#tab_1">2</ref>) nor differences in QOL scores and METS.</s><s xml:id="_GNRSVau">Scores for anxiety and depression were significantly lower (ie, better) for those in the intervention group, compared to the control group, at 6 months (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bhxBU4j">Subgroup analyses for the primary outcome</head><p xml:id="_RjeA9MS"><s xml:id="_62Kv9pz">Subgroup analyses by sex, age, level of activity at baseline, and attendance at rehabilitation are shown in Table <ref type="table" target="#tab_2">3</ref>.</s><s xml:id="_zCxhQSf">While there was no difference in the primary outcome based on sex, age, and attendance for at least 50 % of their rehabilitation program, those who were less active at baseline had significantly greater 6MWD improvements at 6-month follow-up than those who had been initially more active at baseline (Table <ref type="table" target="#tab_2">3</ref>).</s></p><p xml:id="_29dCMMG"><s xml:id="_KERPKjP">Subgroup analysis of participants in cardiac rehabilitation found a non-significant increase in 6MWD at 6 months in the intervention group compared to the controls (unadjusted mean difference 18.9 m, 95 % CI À29.2 to 67.1).</s><s xml:id="_438ZjKj">In addition, for the cardiac rehabilitation subgroup, no significant differences were found between intervention and control group data for either systolic blood pressure (adjusted mean difference À1.3 mmHg, 95 % CI À8.4 to 5.8) or diastolic blood pressure (adjusted mean difference 3.1 mmHg, 95 % CI À1.0 to 7.2) at 6 months.</s></p><p xml:id="_UPq7k6Q"><s xml:id="_JBmCY8B">Subgroup analysis of participants in pulmonary rehabilitation found a non-significant difference between intervention and control data for 6MWD (unadjusted mean difference 38.6 m, 95 % CI À10.6 to 87.8).</s><s xml:id="_RJgpWCd">For those in the pulmonary rehabilitation subgroup, the mean CAT score at 6 months was also significantly lower in the intervention than control group (adjusted mean difference À3.9, 95 % CI À6.6 to À1.3; P = 0.004).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pjFcCKN">Patient reported experience measures</head><p xml:id="_Y2XunEh"><s xml:id="_pWc6gak">Of the 236 participants allocated to the intervention group, 185 (78 %) completed the end-of-study user feedback survey.</s><s xml:id="_4wan2BW">The majority, 160 (of 185, 86 %) read 90-100 % of the text messages and 159 (86 %) agreed or strongly agreed that the messages were useful.</s><s xml:id="_xpW6F4d">In addition, 184 (99 %) found the messages easy to understand, and 106 (57 %) were motivated to change their lifestyle, including increasing their physical activity (84/185, 45 %).</s><s xml:id="_Qy5FPVh">For 89 (48 %) people the messages helped remind them to take their medication.</s><s xml:id="_yJVfaaP">Most (145/185, 78 %) participants reported that a program length of 6 months was just right; comparative minorities stated that the program was either too short (25/185, 13 %) or too long (13/185, 15 %).</s><s xml:id="_AS5rCbP">Almost all participants said the style of language used in the messages was just right (170/185, 92 %); although 8 (4 %) stated they found it too casual and 6 (3 %), too formal.</s><s xml:id="_BRMJ9vN">Furthermore 160 (86 %) participants said that the number of messages received per week was just right, while a minority stated there were either too many (21/ 185, 11 %), or too few (3/185, 2 %).</s><s xml:id="_ajz6a78">Most participants (134/185, 72 %) saved the messages, and around half (99/185, 54 %) shared them with family/friends.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Ppgy7r3">Process outcomes</head><p xml:id="_GzDPg9w"><s xml:id="_8agXpny">Although the message program was one-way, from the hospital to the participant, some people did reply.</s><s xml:id="_d9nqSse">These replies were monitored for safety and content evaluation.</s><s xml:id="_7zRtMjW">In total, 410 replies (from 92 unique numbers) were received.</s><s xml:id="_TFWnMPM">Evaluation of the reply content was summarised into the following categories: to say thank you (157/410, 38 %); to confirm adherence to diet, physical activity, smoking or other health advice in the message (117/410, 28 %); to advise the message was received or to say ok (32/410, 7.8 %); to comment on medications (24/410, 6 %); for administrative reasons, such as a name change or wrong number (9/410, 2 %); to make a comment unrelated to the study (9/410, 2 %); or the reply was blank (62/410, 15 %).</s><s xml:id="_V4nnjEN">The message sending software did not identify any issues with sending messages.</s><s xml:id="_X6XFwM9">There were also no messages received that triggered a safety issue such as reports of chest pain or mental health concerns.</s></p><p xml:id="_ZaJ6mwa"><s xml:id="_JrA4Rg7">In terms of attendance and completion of rehabilitation, there was no significant difference in terms of number of rehabilitation sessions attended between the intervention and control groups (13 sessions, 95 % CI 12.2 to 13.8 vs 14 sessions, 95 % CI 12.5 to 15.6) per week.</s><s xml:id="_FAP46aZ">Nevertheless, after 6 months more participants in the intervention than control group said they had attended rehabilitation (203/207, 98% vs 61/67, 91 %).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wWyfKh5">Discussion</head><p xml:id="_smP8nec"><s xml:id="_3n9JezM">Cardiac and pulmonary rehabilitation recommended guidelines are evidence-based but their reach, completion and sustained behaviour change is suboptimal.</s><s xml:id="_g5CdatT">Results from this RCT trial of ITM, a lifestyle-focussed text message program, for people attending cardiac and pulmonary rehabilitation were mixed.</s><s xml:id="_Seh67Nt">For both the intervention and control group, 6MWD increased between baseline and 6 months; the addition of the ITM did not significantly improve 6MWD performance, or the difference between the groups after adjustment for baseline values.</s><s xml:id="_HZAMK7f">We also found that the ITM program did not significantly improve other cardiovascular risk factors or participant QOL.</s><s xml:id="_wrJgT7K">Nevertheless, people in the intervention group who received ITM messages had improved depression and anxiety scores.</s><s xml:id="_6x4NMsX">They were also more likely to attend their rehabilitation sessions and reported that they found the message contents to be both easy to understand and useful.</s><s xml:id="_6FHFtuU">Participants with COPD who received the intervention also had significantly lower mean CAT at 6 months compared to those in the control group.</s><s xml:id="_x9GnE4M">Scalable strategies that support people with chronic disease and improve attendance and completion of rehabilitation programs are needed.</s><s xml:id="_JMk9ENA">The widespread availability and convenience of mobile devices offer a contemporary form of health communication.</s><s xml:id="_8sHBx4N">Previous research has demonstrated the benefit of text message programs in reducing cardiovascular risk <ref type="bibr" target="#b17">[18]</ref>, but we are unaware of the evaluation of such an intervention in the context of cardiac and pulmonary rehabilitation.</s><s xml:id="_qnxM9QB">While this trial did not replicate the results of TEXTME <ref type="bibr" target="#b17">[18]</ref> in terms of a reduction in cardiovascular risk factors, it did provide evidence that a texting program alongside cardiac and pulmonary rehabilitation is both engaging and useful for participants, and that it reduces anxiety, depression and improves attendance at rehabilitation sessions.</s><s xml:id="_KTr8Gv6">Some factors which may have led to no improvement in the intervention group may include limited health literacy, lack of motivation to change behaviour, a lack of carer support or possibly a lack of self-efficacy <ref type="bibr" target="#b37">[38]</ref>.</s><s xml:id="_hBAZSWH">Potential opportunities for improvement to an ITM service could be to create content with more engagement with health providers, to synchronise messages with digital sensors and health trackers, and also to create more individualised content <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40]</ref>.</s><s xml:id="_Tb9CsWh">The current intervention did improve CAT scores, suggesting that the text message program may have reduced the impact of COPD symptoms on participants' lives <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_KeKddqY">A 2021 systematic review <ref type="bibr" target="#b37">[38]</ref> identified only 1 other study that evaluated a text message program for people with COPD <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_aUy2M45">That study was a pilot of 17 participants and the text message component of the intervention was mainly to provide reminders to participants about entering symptom information, rather than to provide support and advice <ref type="bibr" target="#b40">[41]</ref> Our qualitative findings align with results from other studies of text message programs involving people with heart disease <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b38">39]</ref>, breast cancer <ref type="bibr" target="#b24">[25]</ref>, and diabetes <ref type="bibr" target="#b41">[42]</ref>, where participants consistently reported that messages had high usefulness and provided support.</s><s xml:id="_ZUQMqZW">Furthermore, the pilot study by our group of people with COPD also found that the text reminders served as an effective prompt for exercise, provided a sense of accountability and served as positive motivation for participants <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_thHwywW">Taken all together, these studies suggest that text message programs offering regular reminders and positive and practical tips are well accepted by participants, easy to implement and can be delivered in an automated, yet monitored, way.</s><s xml:id="_yjXdmjd">We suggest that these programs offer a valuable adjunct to further reinforce the content and education in-between sessions of traditional cardiac and pulmonary rehabilitation programs.</s><s xml:id="_nRreV2J">These trials have also highlighted the importance of qualitative evaluation of implementation alongside clinical trials to understand the participant perspective, beyond clinical measures <ref type="bibr" target="#b42">[43]</ref>.</s><s xml:id="_Kd6v4ke">Such evaluations also facilitate continuous review and improvement of message content and ongoing optimisation of engagement strategies <ref type="bibr" target="#b38">[39]</ref>.</s></p><p xml:id="_hcjZxq7"><s xml:id="_aKD689p">Importantly, we found that participants in both cardiac and pulmonary rehabilitation groups improved their 6MWD after receiving the 6-month ITM program.</s><s xml:id="_TJn3BMQ">Specifically, at 6 months the mean 6MWD recorded for cardiac rehabilitation participants was 19 m farther in the intervention group than in the control group; for pulmonary rehabilitation participants this increase was 39 m more in the intervention than control group.</s><s xml:id="_rnHRySV">Neither of these values reached a statistical significance level of P&lt;0.05, but those participating in pulmonary rehabilitation reached clinical significance and those participating in cardiac rehabilitation almost reached clinical significance.</s><s xml:id="_YEn9JE3">A previous study of cardiac rehabilitation participants concluded that a 6MWD improvement of 23 m would be considered clinically significant <ref type="bibr" target="#b35">[36]</ref>.</s><s xml:id="_BV7jaja">For pulmonary rehabilitation participants, a 6MWD improvement of over 30 m would be classed as a clinically significant minimally important difference <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b43">44]</ref>.</s><s xml:id="_maMz6xb">The improvements in 6MWD observed in our groups represent an improvement to a level that would then make increased physical activity more viable for people with cardiac and respiratory disease, a facilitation that would, in turn, improve exercise tolerance and lead to ongoing improvements beyond 6 months since the duration and effectiveness of physical activity continues to be improved as exercise capacity increases.</s><s xml:id="_HKMF345">Of course, it is acknowledged that the 6MWD test has limitations; it is considered a functional assessment rather than a gold standard <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_6P3ZCyg">Importantly, our text message program also successfully facilitated attendance at in-person rehabilitation sessions something that is important based on previous work that has shown that increased attendance at cardiac rehabilitation <ref type="bibr" target="#b45">[46]</ref> and pulmonary rehabilitation <ref type="bibr" target="#b46">[47]</ref> also improves physical and psychosocial outcomes.</s></p><p xml:id="_vBNftpt"><s xml:id="_BvwUa8J">There are several limitations associated with this pragmatic trial.</s><s xml:id="_YW7gVmw">Firstly, the study was conducted in 1 state of Australia and was not powered to detect changes in hospitalisation rates and other hard outcomes.</s><s xml:id="_bzWwXGQ">Secondly, inclusion and exclusion criteria were intentionally broad because the focus of the study was ITM implementation within the context of cardiac and pulmonary rehabilitation, rather than its effectiveness within robust clinical parameters and under strict control of external variables.</s><s xml:id="_35DbMW3">Thirdly, baseline data was collected by local rehabilitation clinicians as part of routine care, leading to potential inter-site variation although primary analyses compared between groups at the 6-month follow-up were from data collected by research assistants blinded to baseline results and group allocation.</s><s xml:id="_ecfqESv">It is also important to note that, for pragmatic reasons (due to the implementation nature of this trial), randomisation was at a ratio of 3:1.</s><s xml:id="_hkFEvnh">This favoured the intervention and allowed more participants the opportunity to receive ITM.</s></p><p xml:id="_3TdyWsC"><s xml:id="_zTjQHXD">In conclusion, the provision of an educational, supportive, textbased message program for people attending cardiac and pulmonary rehabilitation to encourage behaviour change as part of rehabilitation did not have a significant impact on adjusted 6MWD results for all participants, although it did reach clinical significance for those in the pulmonary rehabilitation group only.</s><s xml:id="_Jjj8Stb">In addition, the intervention was well-received by participants: it improved their anxiety and depression scores and increased rehabilitation session attendance rates.</s><s xml:id="_QWHZqvF">We have shown that ITM is suitable for delivery alongside formal rehabilitation programs and offers a scalable strategy that is a useful adjunct to reinforce the content and educational information provided to participants in-between their sessions of traditional, face-to-face cardiac and pulmonary rehabilitation programs.</s><s xml:id="_MbB4y8M">Future text message programs could be individually tailored to deliver physical activity messaging content based on person-centred need using sensor devices.</s><s xml:id="_aHADq5k">A text message program in this context may also provide additional support after completion of a formal program and be highly relevant within the context of the COVID-19 pandemic.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p xml:id="_WMJ8fNX"><s xml:id="_SFEY2Ya">Fig. 1.</s><s xml:id="_Xxp7RCU">Details of a 6-month trial to investigate the integration of text messages into cardiovascular and pulmonary rehabilitation programs.</s><s xml:id="_jeKbyPk">Intervention participants received the messages; control participants did not.Figure Legend: COPD, Chronic obstructive pulmonary disease CVD, cardiovascular disease.</s></p></div></figDesc><graphic coords="4,105.62,55.67,384.24,357.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc><div><p xml:id="_Ru6tYAj"><s xml:id="_SxSbhUz">Fig. 1.</s><s xml:id="_7CSzdZr">Details of a 6-month trial to investigate the integration of text messages into cardiovascular and pulmonary rehabilitation programs.</s><s xml:id="_V5emwEB">Intervention participants received the messages; control participants did not.Figure Legend: COPD, Chronic obstructive pulmonary disease CVD, cardiovascular disease.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_6gfAEeY"><s xml:id="_M6eahyF">Baseline characteristics of all people who were receiving either cardiac or pulmonary rehabilitation and who participated in a 6-month trial of text messages integrated into their rehabilitation program.</s><s xml:id="_Z4TW9XR">Intervention participants received the messages; control participants did not.</s></p></div></figDesc><table><row><cell>Cardiac</cell><cell>Pulmonary</cell><cell>Total cohort</cell></row></table><note xml:id="_4t8NUkC"><p><s xml:id="_bURTzhU">BMI, body mass index; bpm, beats per minute; DBP, diastolic blood pressure; HR, heart rate; MI, myocardial infarction; mins, minutes; m, meters; n, number of participants; SBP, systolic blood pressure; SD, standard deviation.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s xml:id="_4qZJQUB">Primary and secondary outcomes at 6 months for the whole total cohort of people who participated in a 6-month trial into the integration of text messages within cardiac or pulmonary rehabilitation programs.Intervention participants received the messages; control participants did not.6MWD,</s><s xml:id="_YP9Nu2C">6-minute walk test distance; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; HADS, Hospital Anxiety and Depression Scale; IQI, interquartile interval; m, meters; METS, metabolic equivalents; mins, minutes; n, number of participants; SBP, systolic blood pressure; SF-12, short-form 12 health survey.*</s><s xml:id="_TuDbaSC">Adjusted for outcome measures at baseline and participation in cardiac vs pulmonary rehabilitations; Mean difference (95 % confidence interval) for continuous variables; Relative risk (95 % confidence interval) for categorical variables, unless otherwise stated.</s></p></div></figDesc><table><row><cell>Variable</cell><cell>Control</cell><cell>Intervention</cell><cell>Adjusted effect</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>size* (95 % CI)</cell><cell></cell></row><row><cell>Primary Outcome</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean 6MWD (m), mean (95 % CI)</cell><cell>434.5 (400.7 to 468.4)</cell><cell>477.9 (458.5 to 497.4)</cell><cell cols="2">2.2 (À21.2 to 25.6)</cell></row><row><cell>Secondary Outcomes</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SBP (mmHg), mean (95 % CI)</cell><cell>124.6 (120.7 to 128.5)</cell><cell>126.8 (124.5 to 129.1)</cell><cell>0.8 (À3.9 to 5.5)</cell><cell></cell></row><row><cell>SBP &gt;130 mmHg, n (%)</cell><cell>21/63 (33)</cell><cell>71/178 (40)</cell><cell>0.95 (0.65 to 1.38)</cell><cell></cell></row><row><cell>DBP (mmHg), (95 % CI)</cell><cell>74.5 (72.1 to 76.8)</cell><cell>78.7 (77.3 to 80)</cell><cell>2.9 (0.2 to 5.5)</cell><cell></cell></row><row><cell>BMI (kg/m2), mean (95 % CI)</cell><cell>28.5 (27 to 30.1)</cell><cell>28 (27.1 to 29)</cell><cell>0.0 (À0.4 to 0.5)</cell><cell></cell></row><row><cell>BMI &gt;30 kg/m 2 , n (%)</cell><cell>22/63 (35)</cell><cell>61/175 (35)</cell><cell>1.12 (0.9 to 1.38)</cell><cell></cell></row><row><cell>Waist circumference (cm), mean (95 % CI)</cell><cell>101.1 (97.3 to 104.8)</cell><cell>100.4 (98.2 to 102.6)</cell><cell>À2.5 (À5.6 to 0.7)</cell><cell></cell></row><row><cell>&gt;80 % medication adherence, n (%)</cell><cell>64/67 (95)</cell><cell>190/194 (98)</cell><cell>1.03 (0.97 to 1.09)</cell><cell></cell></row><row><cell>Current smoker, n (%)</cell><cell>6/67 (9)</cell><cell>13/194 (7)</cell><cell>1.01 (0.64 to 1.61)</cell><cell></cell></row><row><cell>Heart rate (bpm), mean (95 % CI)</cell><cell>75.7 (71.9 to 79.4)</cell><cell>74.6 (72.4 to 76.7)</cell><cell>0.5 (À3.2 to 4.1)</cell><cell></cell></row><row><cell>METS (min/week), median (IQI)</cell><cell>960 (400 to 2640)</cell><cell>1500 (720 to 2660)</cell><cell>0.93 (0.49 to 1.75)</cell><cell>Âctive</cell></row><row><cell>≥5 days/week x 30mins, n (%)</cell><cell>44/80 (55)</cell><cell>96/236 (41)</cell><cell>0.85 (0.67 to 1.08)</cell><cell></cell></row><row><cell>Sedentary time (min/day), mean (95 % CI)</cell><cell>480.5 (430.4 to 530.6)</cell><cell>422.6 (393.2 to 452)</cell><cell cols="2">À47.3 (À101.7 to 7.1)</cell></row><row><cell>Drink alcohol ≥ once/week, n (%)</cell><cell>32/67 (48)</cell><cell>100/195 (52)</cell><cell>0.91 (0.69 to 1.2)</cell><cell></cell></row><row><cell>Number of standard drinks of alcohol consumed/week, mean (95 % CI)</cell><cell>7.9 (4.8 to 11)</cell><cell>8.2 (6.4 to 10)</cell><cell>0.3 (À3.3 to 3.9)</cell><cell></cell></row><row><cell>Servings of fruit/day, mean (95 % CI)</cell><cell>1.6 (1.3 to 2)</cell><cell>1.8 (1.6 to 2)</cell><cell>0.2 (À0.2 to 0.5)</cell><cell></cell></row><row><cell>Servings of raw vegetables/day, mean (95 % CI)</cell><cell>0.9 (0.7 to 1.1)</cell><cell>0.9 (0.8 to 1)</cell><cell>0 (À0.2 to 0.2)</cell><cell></cell></row><row><cell>Servings of cooked vegetables/day, mean (95 % CI)</cell><cell>1.7 (1.4 to 2.1)</cell><cell>2 (1.7 to 2.2)</cell><cell>0.2 (À0.2 to 0.6)</cell><cell></cell></row><row><cell>Number of meals dining out per week, mean (95 % CI)</cell><cell>1.9 (1.2 to 2.5)</cell><cell>1.8 (1.4 to 2.2)</cell><cell>À0.1 (À0.8 to 0.7)</cell><cell></cell></row><row><cell>Number of rehabilitation sessions attended, mean (95 % CI)</cell><cell>14 (12.5 to 15.6)</cell><cell>13 (12.2 to 13.8)</cell><cell>À0.2 (À1.8 to 1.3)</cell><cell></cell></row><row><cell>Attended ≥1 session of rehabilitation, n (%)</cell><cell>61/67 (91)</cell><cell>203/207 (98)</cell><cell>1.08 (1.0 to 1.16)</cell><cell></cell></row><row><cell>SF12 V2 Physical Health Summary score, mean (95 % CI)</cell><cell>39 (36.2 to 41.8)</cell><cell>41.3 (39.7 to 43)</cell><cell>À0.2 (À2.9 to 2.5)</cell><cell></cell></row><row><cell>SF12 V2 Mental Health Summary score, mean (95 % CI)</cell><cell>45.3 (42.7 to 48)</cell><cell>50.6 (49 to 52.1)</cell><cell>2 (À0.8 to 4.8)</cell><cell></cell></row><row><cell>HADS anxiety score, mean (95 % CI)</cell><cell>7 (6 to 7.9)</cell><cell>5.4 (4.9 to 6)</cell><cell>À1.1 (À2.1 to 0)</cell><cell></cell></row><row><cell>HADS depression score, mean (95 % CI)</cell><cell>6.2 (5.3 to 7.1)</cell><cell>4.1 (3.6 to 4.7)</cell><cell cols="2">À1.3 (À2.2 to À0.3)</cell></row><row><cell>CAT + score, mean (95 % CI)</cell><cell>21.1 (18.6 to 23.6)</cell><cell>17.8 (16.1 to 19.5)</cell><cell cols="2">À3.9 (À6.6 to À1.3)</cell></row><row><cell cols="5">^Adjusted for outcome measures at baseline and participation in cardiac vs pulmonary rehabilitations; proportional odds ratio (95 % confidence</cell></row><row><cell>interval).</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_DkP5has"><p><s xml:id="_CSW6tRD">+ Only assessed in participants attending pulmonary rehabilitation.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p xml:id="_YtY3Buy"><s xml:id="_gcF3FRZ">Subgroup analyses of the 6-minute walk distances (in meters) of people receiving either cardiac or pulmonary rehabilitation and who participated in a 6-month trial of text messages integrated into their rehabilitation program.</s><s xml:id="_BucAbp2">Intervention participants received the messages; control participants did not.</s><s xml:id="_4AUjR5p">Distances are divided by gender, age, level of physical activity at baseline and rehabilitation attendance at 6-month follow-up.</s></p></div></figDesc><table><row><cell>Subgroups</cell><cell></cell><cell>Control (95 % CI)</cell><cell>Intervention (95 % CI)</cell><cell>Mean difference (95 % CI)</cell><cell>P-value for interaction</cell></row><row><cell>Sex</cell><cell>Male</cell><cell>462.3 (436.4 to 488.3)</cell><cell>474.0 (459.1 to 488.9)</cell><cell>11.6 (À18.3 to 41.6)</cell><cell>0.328</cell></row><row><cell></cell><cell>Female</cell><cell>466.2 (434.0 to 498.3)</cell><cell>454.2 (434.7 to 473.6)</cell><cell>À12.0 (À49.2 to 25.1)</cell><cell></cell></row><row><cell>Age</cell><cell>≤65 years</cell><cell>492.5 (457.4 to 527.6)</cell><cell>471.9 (454.5 to 489.2)</cell><cell>À20.7 (À59.5 to 18.2)</cell><cell>0.179</cell></row><row><cell></cell><cell>&gt;65 years</cell><cell>449.9 (425.2 to 474.6)</cell><cell>462.3 (446.3 to 478.4)</cell><cell>12.4 (À16.8 to 41.5)</cell><cell></cell></row><row><cell>Active at baseline</cell><cell>METS ≥600 min/week</cell><cell>499.2 (473.3 to 525.2)</cell><cell>471.1 (458.3 to 483.9)</cell><cell>À28.2 (À57.2 to 0.8)</cell><cell>0.011</cell></row><row><cell></cell><cell>METS &lt;600 min/week</cell><cell>431.8 (388.1 to 475.6)</cell><cell>484.8 (450.7 to 518.9)</cell><cell>53 (À2.2 to 108.1)</cell><cell></cell></row><row><cell>Rehabilitation sessions attended</cell><cell>≥50 %</cell><cell>471.1 (447.8 to 494.4)</cell><cell>471.3 (457.9 to 484.7)</cell><cell>0.2 (À26.7 to 27.2)</cell><cell>0.768</cell></row><row><cell></cell><cell>&lt;50 %</cell><cell>447 (402.1 to 491.9)</cell><cell>455.9 (430.9 to 480.9)</cell><cell>8.9 (À42.5 to 60.3)</cell><cell></cell></row><row><cell cols="3">CI, Confidence Interval; min, minutes; METS, metabolic equivalents.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_ngWzgWY">Acknowledgments</head><p xml:id="_jJfeW4B"><s xml:id="_ZB5FJSc">We thank all the staff from participating hospitals for their support with design, recruitment and implementation of the study.</s><s xml:id="_h8SE9HD">We are grateful for the assistance provided by <rs type="person">Dr Cindy Kok</rs> and <rs type="person">Rebecca MacNaughton</rs> for their roles in the early recruitment along with <rs type="person">Professor John Cullen</rs>, <rs type="person">Professor Ian Caterson</rs> and <rs type="person">Dr Jessica Swinbourne</rs> for their support of the original grant application.</s><s xml:id="_Kf4AehJ">We would also like to acknowledge support from <rs type="person">Mr Tony Barry</rs>, <rs type="person">Dr Aravinda Thiagalingam</rs> and <rs type="person">Ms Anu Indrawansa</rs> for their contributions and hard work with the software management system and monitoring.</s><s xml:id="_dF2QPP5"><rs type="person">Cate Ferry</rs>, Manager from the <rs type="funder">National Heart Foundation of Australia</rs> also provided support for the study.</s></p></div>
			</div>
			<div type="funding">
<div xml:id="_YCNrYvt"><p xml:id="_zz32H2Q"><s xml:id="_BreXHTY">Funding This study was supported by a <rs type="funder">National Heart Foundation 2015</rs> <rs type="grantName">NSW Cardiovascular Research Network Research Development Project Grant</rs> (<rs type="grantNumber">ID: 101134</rs>).</s><s xml:id="_Mq5rtBR">JR is funded by a <rs type="funder">NHMRC</rs> <rs type="grantName">Investigator Grant</rs> (<rs type="grantNumber">GNT1143538</rs>).</s><s xml:id="_zDU4RUh">KH is supported by a <rs type="funder">NHMRC</rs> <rs type="grantName">Investigator Grant</rs> (<rs type="grantNumber">GNT1196724</rs>).</s><s xml:id="_wtRewTJ">ACS was supported by an <rs type="grantName">Australian Government Research Training Program Scholarship</rs> from the <rs type="funder">University of Sydney</rs>.</s><s xml:id="_ydMDj7h">CKC is funded by a <rs type="funder">NHMRC</rs> <rs type="grantName">Investigator Grant</rs> (<rs type="grantNumber">GNT1195326</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_GTck5KM">
					<idno type="grant-number">ID: 101134</idno>
					<orgName type="grant-name">NSW Cardiovascular Research Network Research Development Project Grant</orgName>
				</org>
				<org type="funding" xml:id="_wBPcWrq">
					<idno type="grant-number">GNT1143538</idno>
					<orgName type="grant-name">Investigator Grant</orgName>
				</org>
				<org type="funding" xml:id="_4qgH6vP">
					<idno type="grant-number">GNT1196724</idno>
					<orgName type="grant-name">Investigator Grant</orgName>
				</org>
				<org type="funding" xml:id="_JkyKVHA">
					<orgName type="grant-name">Australian Government Research Training Program Scholarship</orgName>
				</org>
				<org type="funding" xml:id="_n3sjZej">
					<idno type="grant-number">GNT1195326</idno>
					<orgName type="grant-name">Investigator Grant</orgName>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mYH7C5f">Data availability</head><p xml:id="_9QGegAx"><s xml:id="_c5ceQ5V">Data will be made available on request.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_V5kQVnk">Supplementary materials</head><p xml:id="_fMF2UxZ"><s xml:id="_awheyn7">Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.rehab.2023.101800.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main" xml:id="_5EsyeJx">The top 10 causes of death, Factsheet</title>
		<ptr target="https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death" />
		<imprint>
			<date type="published" when="2020-12-09">9 December 2020. 28th November 2022</date>
			<publisher>World Health Organisation</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organisation. The top 10 causes of death, Factsheet. Published online 9 December 2020. Available at https://www.who.int/news-room/fact- sheets/detail/the-top-10-causes-of-death [Accessed 28th November 2022]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main" xml:id="_2ndxFvd">Leading causes of death. fact sheet</title>
		<idno type="DOI">10.1037/e375422004-001</idno>
		<ptr target="https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm" />
		<imprint>
			<date type="published" when="2022-01-13">January 13, 2022. November 2022</date>
			<publisher>US Department of Health &amp; Human Services</publisher>
		</imprint>
		<respStmt>
			<orgName>Centres for Disease Prevention and Control</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Centres for Disease Prevention and Control. Leading causes of death. fact sheet. US Department of Health &amp; Human Services. Last updated January 13, 2022. Avail- able at https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm [Accessed 28th November 2022]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main" xml:id="_ZsxbKQx">Non-communicable diseases</title>
		<ptr target="http://www.who.int/mediacentre/factsheets/fs355/en/" />
		<imprint>
			<date type="published" when="2017-11">2017. November 2022</date>
			<publisher>World Health Organization</publisher>
		</imprint>
	</monogr>
	<note>Fact sheet</note>
	<note type="raw_reference">World Health Organization. Non-communicable diseases, Fact sheet. 2017. Avail- able at http://www.who.int/mediacentre/factsheets/fs355/en/ [Accessed 28th November 2022]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_8BACxCb">Population trends of recurrent coronary heart disease event rates remain high</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Briffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hobbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tonkin</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.110.957944</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x8M6PuX">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="107" to="113" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Briffa TG, Hobbs MS, Tonkin A, et al. Population trends of recurrent coronary heart disease event rates remain high. Circ Cardiovasc Qual Outcomes 2011;4:107-13.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_xYBjet8">Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Chew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Astley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Aliprandi-Costa</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2013-305296</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7gTQHcG">Heart</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1281" to="1288" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Hyun K, Chew DP, Astley C, Chow C, Aliprandi-Costa B, et al. Prescrip- tion of secondary prevention medications, lifestyle advice, and referral to rehabil- itation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand. Heart 2014;100(16):1281-8.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ehKPYBc">Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jolly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rao-Melacini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kaa</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.109.891523</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2CEPZQ4">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="750" to="758" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121(6):750-8.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_G2u8XhZ">Toward reducing COPD hospitalization</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Macintyre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_J2cAJJF">Respir Care</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="127" to="128" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">MacIntyre NR. Toward reducing COPD hospitalization. Respir Care 2019;65 (1):127-8.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_qs9pXB7">Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Noyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sethi</surname></persName>
		</author>
		<idno type="DOI">10.1513/annalsats.201712-913oc</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pFj5e7B">Ann Am Thorac Soc</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="837" to="845" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jacobs DM, Noyes K, Zhao J, Gibson W, Murphy TF, Sethi S, et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary dis- ease in the nationwide readmissions database. Ann Am Thorac Soc 2018;15 (7):837-45.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_kVXN2eb">An integrated and coordinated approach to preventing recurrent coronary heart disease events in Australia</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Briffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kinsman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Maiorana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zecchin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Davidson</surname></persName>
		</author>
		<idno type="DOI">10.5694/j.1326-5377.2009.tb02636.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kVCWuBy">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="683" to="686" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Briffa TG, Kinsman L, Maiorana AJ, Zecchin R, Redfern J, Davidson PM, et al. An integrated and coordinated approach to preventing recurrent coronary heart dis- ease events in Australia. Med J Aust 2009;190(12):683-6.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_YzRFwu6">Pulmonary rehabilitation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Ries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Bauldoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Carlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Casaburi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Emery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Mahler</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.06-2418</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YZxc2We">Chest</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="4S" to="42S" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmo- nary rehabilitation. Chest 2007;131(5 Suppl):4S-42S.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_VTwGUrU">Meta-analysis: secondary prevention programs for patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hartling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vandermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Mcalister</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-143-9-200511010-00010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6s9DuYN">Ann Int Med</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">659</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary pre- vention programs for patients with coronary artery disease. Ann Int Med 2005;143(9):659.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_HbQw2SN">Clinical research in cardiac rehabilitation and secondary prevention</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Sanderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Ades</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ABWkUjQ">J Cardiopulm Rehabil Prev</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="333" to="341" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Savage PD, Sanderson BK, Brown TM, Berra K, Ades PA. Clinical research in cardiac rehabilitation and secondary prevention. J Cardiopulm Rehabil Prev 2011;31 (6):333-41.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_gsb54Vp">Optimising secondary prevention and cardiac rehabilitation for atherosclerotic cardiovascular disease during the COVID-19 pandemic: a position statement from the cardiac society of Australia and New Zealand (CSANZ)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Nicholls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Astley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Briffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clark</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.hlc.2020.04.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pwYe6ff">Heart Lung Circ</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="99" to="104" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nicholls SJ, Nelson M, Astley C, Briffa T, Brown A, Clark R, et al. Optimising secondary prevention and cardiac rehabilitation for atherosclerotic cardiovascular disease dur- ing the COVID-19 pandemic: a position statement from the cardiac society of Aus- tralia and New Zealand (CSANZ). Heart Lung Circ 2020;29(7):e99-104.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_tzxHrXk">Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic</title>
		<author>
			<persName><forename type="first">Mab</forename><surname>Siddiq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Rathore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Clegg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Rasker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_weAtqUE">Turk J Phys Med Rehabil</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="480" to="494" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pan- demic. Turk J Phys Med Rehabil 2020;66(4):480-94.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_aR8JC6X">Mobile phonebased interventions for smoking cessation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcrobbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Borland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cdeEP6B">Cochrane Database of Syst Rev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">6611</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone- based interventions for smoking cessation. Cochrane Database of Syst Rev 2012;11:CD006611.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_tEWqU98">A text message -based intervention for weight loss: randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Raab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zabinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Rock</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.1100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hBs79qy">J Med Int Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e1</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patrick K, Raab F, Adams MA, Dillon L, Zabinski M, Rock CL, et al. A text message -based intervention for weight loss: randomized controlled trial. J Med Int Res 2009;11(1):e1.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_ntbgB6e">Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hurling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Catt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Hurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.2196/jmir.9.2.e7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mDSEc7f">J Med Int Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hurling R, Catt M, De Boni M, Fairley BW, Hurst T, Murray P, et al. Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial. J Med Int Res 2007;9(2):e7.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_P3nwu7P">Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hackett</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.10945</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ytUMbj8">J Am Med Assoc</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">1255</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of life- style-focused text messaging on risk factor modification in patients with coronary heart disease. J Am Med Assoc 2015;314(12):1255.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_sKwB29x">Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program Daker-White G</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Coorey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UGmRRgx">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">163929</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Santo K, Coorey G, Thakkar J, Hackett M, Thiagalingam A, et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms asso- ciated with a text message support program Daker-White G, editor PLoS ONE 2016;11(10):e0163929.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_Pd4NsSV">Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">E</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nghiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QrbQWAH">Heart</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1" to="894" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burn E, Nghiem S, Jan S, Redfern J, Rodgers A, Thiagalingam A, et al. Cost-effective- ness of a text message programme for the prevention of recurrent cardiovascular events. Heart 2017;103(12) 893.1-894.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_QgRAbQr">ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hafiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raeside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spencer</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-023863</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KkdXj8h">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">23863</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Hyun K, Singleton A, Hafiz N, Raeside R, Spencer L, et al. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open 2019;9(3):e023863.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_BdYxkCA">CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.c332</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fSuwq8a">Br Med J</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="issue">mar23 1</biblScope>
			<biblScope unit="page" from="332" to="332" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guide- lines for reporting parallel group randomised trials. Br Med J 2010;340 (mar23 1) c332-2.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_Rb9jDen">Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9BV4rRf">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett M, Mooney J, et al. Devel- opment of a set of mobile phone text messages designed for prevention of recur- rent cardiovascular events. Eur J Prev Cardiol 2012;21(4):492-9.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_UJfsjC6">Co-designing a lifestyle-focused text message intervention for women after breast cancer treatment: mixed methods study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raeside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Maka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Hyun</surname></persName>
		</author>
		<idno type="DOI">10.2196/27076</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9KmEq78">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">27076</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singleton A, Raeside R, Partridge SR, Hayes M, Maka K, Hyun KK, et al. Co-design- ing a lifestyle-focused text message intervention for women after breast cancer treatment: mixed methods study. J Med Internet Res 2021;23(6):e27076.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_ea3ptwE">Supporting breast cancer survivors via text messages: reach, acceptability, and utility of EMPOWER-SMS</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raeside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Partridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tat-Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Che</forename><forename type="middle">Mun</forename><surname>Sum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11764-021-01106-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AXckFtB">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1165" to="1175" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singleton AC, Raeside R, Partridge SR, Tat-Ko J, Che Mun Sum S, Hyun KK, et al. Supporting breast cancer survivors via text messages: reach, acceptability, and utility of EMPOWER-SMS. J Cancer Surviv 2022;16(6):1165-75.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_Wxn348k">The six-minute walk test: a useful metric for the cardiopulmonary patient</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rasekaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Naughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Holland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8UXMFt9">Int Med J</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="495" to="501" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Int Med J 2009;39(8):495-501.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main" xml:id="_SWGwFW6">Six Minute Walk Test (6MWT) instructions</title>
		<author>
			<persName><forename type="first">Heart</forename><surname>Online</surname></persName>
		</author>
		<idno type="DOI">10.7717/peerj.19755/fig-1</idno>
		<imprint>
			<date type="published" when="2023-06-08">8th June 2023</date>
		</imprint>
	</monogr>
	<note>Available at 6MWT_stan-dardised_instructions.pdf heartonline.org.au</note>
	<note type="raw_reference">Heart Online. Six Minute Walk Test (6MWT) instructions. Available at 6MWT_stan- dardised_instructions.pdf (heartonline.org.au) [Accessed 8th June 2023].</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main" xml:id="_f3HecZB">Anthropometric standardization reference manual</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Lohman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Martorell</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1988">1988</date>
			<publisher>Human Kinetics</publisher>
			<biblScope unit="page" from="55" to="80" />
			<pubPlace>Champaign, IL</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics; 1988. p. 55-80.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_GrnuCZ5">Outcome criteria in smoking cessation trials: proposal for a common standard</title>
		<author>
			<persName><forename type="first">R</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hajek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stapleton</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1360-0443.2004.00995.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hhJrA4r">Addiction</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="299" to="303" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<idno type="DOI">10.5114/hpc.2018.80229</idno>
		<ptr target="https://www.who.int/docs/default-source/ncds/ncd-surveillance/gpaq-analysis-guide.pdf" />
		<title level="m" xml:id="_6hVmyyW">Global Physical Activity Questionnaire</title>
		<imprint>
			<publisher>GPAQ) Analysis Guide</publisher>
			<date type="published" when="2011-07-03">2011. 3rd July 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organisation. Global Physical Activity Questionnaire (GPAQ) Analy- sis Guide. 2011. Available at https://www.who.int/docs/default-source/ncds/ncd- surveillance/gpaq-analysis-guide.pdf [Accessed 3rd July 2023].</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<ptr target="http://apps.who.int/iris/bitstream/10665/43376/1/9241593830_eng.pdf37" />
		<title level="m" xml:id="_HnAyYyx">The who step wise approach to chronic disease risk factor surveillance (STEPS)</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organisation</publisher>
			<date type="published" when="2008-07-03">2008. 3rd July 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The who step wise approach to chronic disease risk factor surveillance (STEPS). Geneva: World Health Organisation, 2008. Available at http://apps.who.int/iris/ bitstream/10665/43376/1/9241593830_eng. pdf 37 [Accessed 3rd July 2023].</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_ndNrrmF">A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kosinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Keller</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005650-199603000-00003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jttGUbb">Med Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="220" to="233" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34 (3):220-33.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_czj8Cgx">The hospital anxiety and depression scale</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Zigmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Snaith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yWdQBjA">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="361" to="370" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-70.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_j5YyCEM">Development and first validation of the COPD assessment test</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wiklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W-H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kline</forename><surname>Leidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00102509</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k85gAuK">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="648" to="654" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J 2009;34(3):648-54.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_KW6pFPU">Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bestall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garrod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garnham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wedzicha</surname></persName>
		</author>
		<idno type="DOI">10.1136/thx.54.7.581</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Uf75dFc">Thorax</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="581" to="586" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-6.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_GXXsCyP">Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome</title>
		<author>
			<persName><forename type="first">V</forename><surname>Gremeaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Troisgros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Benaïm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hannequin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Casillas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_heDqN9a">Arch Phys Med Rehabil</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="611" to="619" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gremeaux V, Troisgros O, Benaïm S, Hannequin A, Laurent Y, Casillas JM, et al. Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome. Arch Phys Med Rehabil 2011;92(4):611-9.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_KvF5wYn">An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Puhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Andrianopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Hernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MGNG6U6">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1447" to="1478" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Tho- racic Society: measurement properties of field walking tests in chronic respira- tory disease. Eur Respir J 2014;44(6):1447-78.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_vPPRVTm">Short message services interventions for chronic disease management: a systematic review</title>
		<author>
			<persName><forename type="first">Chioma</forename><surname>Ebuenyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schnoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Versluis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chavannes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZeSdxxb">Clin eHealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="24" to="29" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chioma Ebuenyi M, Schnoor K, Versluis A, Meijer E, Chavannes NH. Short message services interventions for chronic disease management: a systematic review. Clin eHealth 2021;4:24-9.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_4vjdgcf">Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Klimis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brieger</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.121.056161</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gwz7Wnp">Circulation</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1443" to="1455" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Klimis H, Thiagalingam A, Redfern J, Hillis GS, Brieger D, et al. Text mes- sages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation 2022;145(19):1443-55.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_JAcEWJu">Digital health innovations to improve cardiovascular disease care</title>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11883-020-00889-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mh434j5">Curr Ather Rep</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">71</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Santo K, Redfern J. Digital health innovations to improve cardiovascular disease care. Curr Ather Rep 2020;22:71.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_Kk2bhvt">Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nguyen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zMKDsBf">Int J Chron Obstruct Pulmon Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">301</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nguyen H. Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD. Int J Chron Obstruct Pulmon Dis 2009;4:301.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_QQZ2cke">Text messaging support for patients with diabetes or coronary artery disease (Sup-portMe): protocol for a pragmatic randomised controlled trial</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Hng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sms</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haider</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-025923</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ndSBFty">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e025923</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheung NW, Redfern J, Thiagalingam A, Hng TM, Islam SMS, Haider R, et al. Text messaging support for patients with diabetes or coronary artery disease (Sup- portMe): protocol for a pragmatic randomised controlled trial. BMJ Open 2019;9 (6):e025923.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_6cXXBdS">Evaluating the public health impact of health promotion interventions: the RE-AIM framework</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Glasgow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Boles</surname></persName>
		</author>
		<idno type="DOI">10.2105/ajph.89.9.1322</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C7zVxcE">Am J Public Health</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1322" to="1327" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999;89 (9):1322-7.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_Ud9PvYp">Sixminute-walk test in chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Polkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Spruit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pinto-Plata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vestbo</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201209-1596oc</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vkDQNQs">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="382" to="386" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, et al. Six- minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(4):382-6.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_V5s2fQX">Home-based and remote functional exercise testing in cardiac conditions, during the covid-19 pandemic and beyond: a systematic review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Louis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bertram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Morris</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.physio.2021.12.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dPa5f5u">Physiotherapy</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="27" to="35" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hwang R, Fan T, Bowe R, Louis M, Bertram M, Morris NR, et al. Home-based and remote functional exercise testing in cardiac conditions, during the covid-19 pandemic and beyond: a systematic review. Physiotherapy 2022;115:27-35.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_GUjBuzf">On-site programmatic attendance to cardiac rehabilitation and the healthy-adherer effect</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Alter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zagorski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marzolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Forhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Oh</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487314544084</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_avzkq3X">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1232" to="1246" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alter DA, Zagorski B, Marzolini S, Forhan M, Oh PI. On-site programmatic atten- dance to cardiac rehabilitation and the healthy-adherer effect. Eur J Prev Cardiol 2015;22(10):1232-46.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_8xfXVrD">Attendance at pulmonary rehabilitation classes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cassidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Turnbull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gardani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kirkwood</surname></persName>
		</author>
		<idno type="DOI">10.1177/1479972314527469</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JyhPruy">Chron Respir Dis</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="95" to="102" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cassidy S, Turnbull S, Gardani M, Kirkwood K. Attendance at pulmonary rehabili- tation classes. Chron Respir Dis 2014;11(2):95-102.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
